Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TachoSil for intra-operative haemostasis in paediatric liver resection / segmental liver transplantation
2004-005028-42Phase 3Terminated
- Sponsor
- Takeda
- Start
- Jan 2006
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tachosil in Not applicable, sponsored by Takeda. Primary endpoints: Time to intra-operative haemostasis and Safety follow-up. Started Jan 2006; status: terminated.
02
Drugs
tachosil
03
Conditions
Not applicable
Beyond the preview
Go deeper on 2004-005028-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005028-42.